AstraZeneca PLC (AZN)
186.68
-0.83
(-0.44%)
USD |
NYSE |
Apr 28, 16:00
184.80
-1.88
(-1.01%)
Pre-Market: 08:56
AstraZeneca Research and Development Expense (TTM) : 13.84B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GSK Plc | 9.632B |
| Amgen, Inc. | 7.281B |
| Gilead Sciences, Inc. | 5.688B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Moderna, Inc. | 2.917B |